Lingtong Zhi

PR China
Xinxiang, Puerto Rico

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 19 publications

Engineered PD1-NKG2D Dual-CAR NK92 cells broaden antitumor target recognition in preclinical tumor models.

Engineered PD1-NKG2D Dual-CAR NK92 cells broaden antitumor target recognition in preclinical tumor models.

Journal: Journal of translational medicine

Published: April 13, 2026

Mechanisms and strategies for reversing NK cell exhaustion in tumor immunotherapy.

Mechanisms and strategies for reversing NK cell exhaustion in tumor immunotherapy.

Journal: Experimental and molecular pathology

Published: June 05, 2025

A membrane-bound IL-2 promotes CAR-NK cell proliferation, anti-apoptosis and anti-tumor activity.

A membrane-bound IL-2 promotes CAR-NK cell proliferation, anti-apoptosis and anti-tumor activity.

Journal: Biochemical and biophysical research communications

Published: May 14, 2025

Correction: CAR-NK cells with dual targeting of PD-L1 and MICA/B in lung cancer tumor models.

Correction: CAR-NK cells with dual targeting of PD-L1 and MICA/B in lung cancer tumor models.

Journal: BMC cancer

Published: March 03, 2025

CAR-NK cells with dual targeting of PD-L1 and MICA/B in lung cancer tumor models.

CAR-NK cells with dual targeting of PD-L1 and MICA/B in lung cancer tumor models.

Journal: BMC cancer

Published: November 07, 2024

The pivotal role of CRIHSP sequences in orchestrating antigen receptor diversity and genomic stability within antigen receptor germline genes.

The pivotal role of CRIHSP sequences in orchestrating antigen receptor diversity and genomic stability within antigen receptor germline genes.

Journal: International journal of biological macromolecules

Published: October 25, 2024

A novel MICA/B-targeted chimeric antigen receptor augments the cytotoxicity of NK cells against tumor cells.

A novel MICA/B-targeted chimeric antigen receptor augments the cytotoxicity of NK cells against tumor cells.

Journal: Biochemical and biophysical research communications

Published: April 01, 2024

Challenges in the Development of NK-92 Cells as an Effective Universal Off-the-Shelf Cellular Therapeutic.

Challenges in the Development of NK-92 Cells as an Effective Universal Off-the-Shelf Cellular Therapeutic.

Journal: Journal of immunology (Baltimore, Md. : 1950)

Published: March 29, 2024

Intrinsic and extrinsic factors determining natural killer cell fate: Phenotype and function.

Intrinsic and extrinsic factors determining natural killer cell fate: Phenotype and function.

Journal: Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie

Published: May 17, 2023

The SpyCatcher-SpyTag interaction mediates tunable anti-tumor cytotoxicity of NK cells.

The SpyCatcher-SpyTag interaction mediates tunable anti-tumor cytotoxicity of NK cells.

Journal: Molecular immunology

Published: May 16, 2023

Engagement of an optimized lentiviral vector enhances the expression and cytotoxicity of CAR in human NK cells.

Engagement of an optimized lentiviral vector enhances the expression and cytotoxicity of CAR in human NK cells.

Journal: Molecular immunology

Published: November 14, 2022

In Vitro Nanobody Library Construction by Using Gene Designated-Region Pan-Editing Technology.

In Vitro Nanobody Library Construction by Using Gene Designated-Region Pan-Editing Technology.

Journal: Biodesign research

Published: January 23, 2022

Showing 1-12 of 19

Last Updated: 09/26/2026